by admin | Jan 20, 2023 | Blog
Cell-free DNA and circulating tumor cells: which has more potential in precision oncology? Many studies have demonstrated the advantages of technologies based on liquid biopsy in the genomic profiling of cancer patients. Blood-derived cell-free DNA (cfDNA)- and...
by admin | Dec 12, 2022 | Blog
Diagnostics solutions by liquid biopsy for women with endometriosis Liquid biopsy solutions were invented mainly for oncological diseases. In our newest blog, we look at a benign disease that could also benefit from innovative diagnostic approaches. What is...
by admin | Nov 15, 2022 | Blog
Blood-derived biomarkers in prostate cancer Prostate cancer (PCa) is the second most commonly occurring cancer in men, accounting for 14.1% of all male cases, and the fourth most common cancer overall (Sung et al., 2021). There were more than 1.4 million new cases of...
by admin | Oct 24, 2022 | Blog
Clonal evolution monitoring in cancer with liquid biopsy In the last part of our blog series, we will focus on the process by which subclones in tumors change over time and how liquid biopsy can be applied in monitoring clonal evolution and heterogeneity in tumors....
by admin | Sep 28, 2022 | News
Team-building in Badacsony The CEO of Clinomics Korea, Prof. Jong Bhak, visited us, so we organized a team-building event in Badacsony, which is one of the most beautiful places in Hungary around Balaton. We are glad that such a great team can work together. Recent...
